1. Teveten [Prescribing Information]. North Chicago, IL: AbbVie Inc.; July 2014.
2. Diovan [Prescribing Information]. East Hanover, NJ: Novartis; September 2014.
3. Diovan HCT [Prescribing Information]. East Hanover, NJ: Novartis; September 2014.
5. American Hospital Formulary Service Drug Information. AHFS Web site. Available at: http://www.ashp.org/ahfs/index.cfm. Accessed June 2015.
6. Rodgers JE and Patterson JH. Angiotensin II receptor blockers: Clinical relevance and therapeutic role. Am J Health-Syst Pharm. 2001;58:671-683.
7. American Diabetes Association Clinical Practice Recommendations - 2015. Diabetes Care. 2015;38:(Suppl 1): S1-94.
8. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311 (5): 507-520.
9. Dahlof B, Devereux RB, Kjeldsen SE, et al for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A Randomized trial against atenolol. The Lancet. 2002;359:995-1003.
10. Exforge [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; September 2014.
11. Exforge HCT [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; September 2014.
12. Yancy CW, Jessup M et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128:e240-327.